Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. (LTUS) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 7 transactions totaling $404.3K, demonstrating a bearish sentiment with -$404.3K in net insider flow. The most recent transaction on Jan 24, 2011 involved a transaction of 498,646 shares valued at $0.
LTUS Insider Activity Summary
Who Is Buying LTUS Stock?
No significant insider buying has been recorded for LTUS in the recent period.
Who Is Selling LTUS Stock?
No significant insider selling has been recorded for LTUS in the recent period.
Is Lotus Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LTUS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$404.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
LTUS Frequently Asked Questions
Understanding LTUS Insider Activity
Insider trading at Lotus Pharmaceuticals, Inc. (LTUS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading LTUS stock, having executed 7 transactions in the past 90 days. The most active insider is Technology Group Inc Genesis (Executive), who has made 2 transactions totaling $374.0K.
Related Tools
Track Lotus Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at LTUS file new Form 4 transactions